Guided Therapeutics (GTHP) FCF Margin Growth (1y) (2012 - 2025)
Guided Therapeutics (GTHP) FCF Margin Growth (1y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -80.00 |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 473.00 |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -192.00 |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -431.00 |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -1,716.00 |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 2,833.00 |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -125.00 |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 2,811.00 |
| 10 | Guided Therapeutics | 20.78 Mn | 20.72 Mn | 458,000.00 | 3.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.32 Mn |
| Dec 31, 2024 | -3.22 Mn |
| Mar 31, 2024 | 60,152.00 |
| Jun 30, 2023 | 632,455.00 |
| Mar 31, 2023 | 159,182.00 |
| Sep 30, 2022 | -1.65 Mn |
| Jun 30, 2022 | 2.75 Mn |
| Dec 31, 2021 | 153,733.00 |
| Sep 30, 2021 | -300,875.00 |
| Dec 31, 2020 | -5,525.00 |
| Sep 30, 2020 | 2.20 Mn |
| Dec 31, 2019 | -52,827.00 |
| Sep 30, 2019 | 225,000.00 |
| Jun 30, 2019 | -1.62 Mn |
| Mar 31, 2019 | 861,667.00 |
| Dec 31, 2018 | -12,085.00 |
| Sep 30, 2018 | -2.53 Mn |
| Jun 30, 2018 | -276,193.00 |
| Mar 31, 2018 | -771,667.00 |
| Dec 31, 2017 | -66,983.00 |